Cairo - Mubasher: Kahira Pharmaceuticals registered an increase of 5.6% to EGP 26.6 million in net profits for the five-month period ended November 2015.
The firm saw net profits of EGP 25.2 million for the similar period of the preceding year.
The drug firm's revenues stood at EGP 213.4 million for this period of 2015, up from EGP 186.5 million a year earlier.
The company's net profits stood at EGP 14.086 million in the first quarter of the fiscal year 2015/16, an increase 6.7% from EGP 13.197 million for the corresponding period of FY 2014/15.
